Antibody is critical for the clearance of murine norovirus infection

Journal of Virology

Volumn 82, Issue 13, 2008, Pages 6610-6617

  Chachu, Karen A ^a   Strong, David W ^a   LoBue, Anna D ^b   Wobus, Christiane E ^a,c   Baric, Ralph S ^b   Virgin IV, Herbert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; MOUSE; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; SPLEEN CELL; VIRAL GASTROENTERITIS; VIRUS TITRATION; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CALICIVIRIDAE INFECTIONS; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROENTERITIS; HOMEODOMAIN PROTEINS; MICE; MICE, KNOCKOUT; NOROVIRUS; STATISTICS, NONPARAMETRIC;

MURINE NOROVIRUS; MUS; NOROVIRUS;

EID: 45749147427     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00141-08     Document Type: Article

References (60)

1. Ball, J. M., D. Y. Graham, A. R. Opekun, M. A. Gilger, R. A. Guerrero, and M. K. Estes. 1999. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology 117:40-48.
2. Ball, J. M., M. E. Hardy, R. L. Atmar, M. E. Conner, and M. K. Estes. 1998. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J. Virol. 72:1345-1353.
3. Barkon, M. L., B. L. Haller, and H. W. Virgin. 1996. Circulating IgG can play a critical role in clearance of intestinal reovirus infection. J. Virol. 70:1109-1116.
4. Burstin, S. J., D. R. Spriggs, and B. N. Fields. 1982. Evidence for functional domains on the reovirus type 3 hemagglutinin. Virol. 117:146-155.
5. Cheetham, S., M. Souza, T. Meulia, S. Grimes, M. G. Han, and L. J. Saif. 2006. Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J. Virol. 80:10372-10381.
6. Cuff, C. F., E. Lavi, C. K. Cebra, J. J. Cebra, and D. H. Rubin. 1990. Passive immunity to fatal reovirus serotype 3-induced meningoencephalitis mediated by both secretory and transplacental factors in neonatal mice. J. Virol. 64:1256-1263.
7. Dermody, T. S., M. L. Nibert, R. Bassel Duby, and B. N. Fields. 1990. A sigma 1 region important for hemagglutination by serotype 3 reovirus strains. J. Virol. 64:5173-5176.
8. de Wit, M. A., M. P. Koopmans, L. M. Kortbeek, W. J. Wannet, J. Vinje, F. van Leusden, A. I. Bartelds, and Y. T. van Duynhoven. 2001. Sensor, a population-based cohort study on gastroenteritis in The Netherlands: incidence and etiology. Am. J. Epidemiol. 154:666-674.
9. Dolin, R., N. R. Blacklow, H. DuPont, R. F. Buscho, R. G. Wyatt, J. A. Kasel, R. Hornick, and R. M. Chanock. 1972. Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc. Soc. Exp. Biol. Med. 140:578-583.
10. Dolin, R., A. G. Levy, R. G. Wyatt, T. S. Thornhill, and J. D. Gardner. 1975. Viral gastroenteritis induced by the Hawaii agent. Jejunal histopathology and serologic response. Am. J. Med. 59:761-768.
11. Fankhauser, R. L., J. S. Noel, S. S. Monroe, T. Ando, and R. I. Glass. 1998. Molecular epidemiology of "Norwalk-like viruses" in outbreaks of gastroenteritis in the United States. J. Infect. Dis. 178:1571-1578.
12. Franco, M. A., and H. B. Greenberg. 1999. Immunity to rotavirus infection in mice. J. Infect. Dis. 179(Suppl. 3):S466-S469.
13. Graham, D. Y., X. Jiang, T. Tanaka, A. R. Opekun, H. P. Madore, and M. K. Estes. 1994. Norwalk virus infection of volunteers: new insights based on improved assays. J. Infect. Dis. 170:34-43.
14. Green, K. Y., J. F. Lew, X. Jiang, A. Z. Kapikian, and M. K. Estes. 1993. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J. Clin. Microbiol. 31:2185-2191.
15. Guerrero, R. A., J. M. Ball, S. S. Krater, S. E. Pacheco, J. D. Clements, and M. K. Estes. 2001. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J. Virol. 75:9713-9722.
16. Harrington, P. R., L. Lindesmith, B. Yount, C. L. Moe, and R. S. Baric. 2002. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J. Virol. 76:12335-12343.
17. Hsu, C. C., L. K. Riley, H. M. Wills, and R. S. Livingston. 2006. Persistent infection with and serologic cross-reactivity of three novel murine noroviruses. Comp. Med. 56:247-251.
18. Hsu, C. C., C. E. Wobus, E. K. Steffen, L. K. Riley, and R. S. Livingston. 2005. Development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase PCR assay to detect murine norovirus 1 infection in mice. Clin. Diagn. Lab. Immunol. 12:1145-1151.
19. Hutson, A. M., R. L. Atmar, D. M. Marcus, and M. K. Estes. 2003. Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J. Virol. 77:405-415.
20. Jiang, X., D. O. Matson, G. M. Ruizpalacios, J. Hu, J. Treanor, and L. K. Pickering. 1995. Expression, self-assembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein. J. Clin. Microbiol. 33:1452-1455.
21. Jiang, X., M. Wang, D. Y. Graham, and M. K. Estes. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66:6527-6532.
22. Johnson, P. C., J. J. Mathewson, H. L. DuPont, and H. B. Greenberg. 1990. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J. Infect. Dis. 161:18-21.
23. Karst, S. M., C. E. Wobus, M. Lay, J. Davidson, and H. W. Virgin. 2003. STATl-dependent innate immunity to a Norwalk-like virus. Science 299: 1575-1578.
24. Katpally, U., C. E. Wobus, K. Dryden, H. W. Virgin, and T. J. Smith. 2008. Structure of antibody neutralized murine norovirus and unexpected differences to viruslike particles. J. Virol. 82:2079-2088.
25. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350:423-426.
26. Kuklin, N. A., L. Rott, N. Feng, M. E. Conner, N. Wagner, W. Muller, and H. B. Greenberg. 2001. Protective intestinal anti-rotavirus B-cell immunity is dependent on alpha 4 beta 7 integrin expression but does not require IgA antibody production. J. Immunol. 166:1894-1902.
27. Lindesmith, L., C. Moe, J. LePendu, J. A. Frelinger, J. Treanor, and R. S. Baric. 2005. Cellular and humoral immunity following Snow Mountain virus challenge. J. Virol. 79:2900-2909.
28. Lindesmith, L., C. Moe, S. Marionneau, N. Ruvoen, X. Jiang, L. Lindblad, P. Stewart, J. LePendu, and R. Baric. 2003. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9:548-553.
29. LoBue, A. D., L. Lindesmith, B. Yount, P. R. Harrington, J. M. Thompson, R. E. Johnston, C. L. Moe, and R. S. Baric. 2006. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 24:5220-5234.
30. Lochridge, V. P., and M. E. Hardy. 2007. A single amino acid substitution in the P2 domain of VP1 of murine norovirus is sufficient for escape from antibody neutralization. J. Virol.
31. Macpherson, A. J., A. Lamarre, K. McCoy, G. R. Harriman, B. Odermatt, G. Dougan, H. Hengartner, and R. M. Zinkernagel. 2001. IgA production without mu or delta chain expression in developing B cells. Nat. Immunol. 2:625-631.
32. Matsui, S. M., and H. B. Greenberg. 2000. Immunity to calicivirus infection. J. Infect. Dis. 181(Suppl. 2):S331-S335.
33. McClellan, J. S., S. A. Tibbetts, S. Gangappa, K. A. Brett, and H. W. Virgin. 2004. Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gamma-herpesvirus latency. J. Virol. 78:6836-6845.
34. McClellan, K. B., S. Gangappa, S. H. Speck, and H. W. Virgin. 2006. Antibody-independent control of gamma-herpesvirus latency via B-cell induction of antiviral T-cell responses. PLoS Pathog. 2:e58.
35. Mumphrey, S. M., H. Changotra, T. N. Moore, E. R. Heimann-Nichols, C. E. Wobus, M. J. Reilly, M. Moghadamfalahi, D. Shukla, and S. M. Karst. 2007. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J. Virol. 81:3251-3263.
36. Nagler-Anderson, C., C. Terhoust, A. K. Bhan, and D. K. Podolsky. 2001. Mucosal antigen presentation and the control of tolerance and immunity. Trends Immunol. 22:120-122.
37. Okhuysen, P. C., X. Jiang, L. Ye, P. C. Johnson, and M. K. Estes. 1995. Viral shedding and fecal IgA response after Norwalk virus infection. J. Infect. Dis. 171:566-569.
38. O'Neal, C. M., G. R. Harriman, and M. E. Conner. 2000. Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A. J. Virol. 74:4102-4109.
39. Parrino, T. A., D. S. Schreiber, J. S. Trier, A. Z. Kapikian, and N. R. Blacklow. 1977. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N. Engl. J. Med. 297:86-89.
40. Perdue, K. A., K. Y. Green, M. Copeland, E. Barron, M. Mandel, L. J. Faucette, E. M. Williams, S. V. Sosnovtsev, W. R. Elkins, and J. M. Ward. 2007. Naturally occurring murine norovirus infection in a large research institution. J. Am. Assoc. Lab. Anim. Sci. 46:38-44.
41. Periwal, S. B., K. R. Kourie, N. Ramachandaran, S. J. Blakeney, S. DeBruin, D. Zhu, T. J. Zamb, L. Smith, S. Udem, J. H. Eldridge, K. E. Shroff, and P. A. Reilly. 2003. A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine. Vaccine 21:376-385.
42. Sherry, B., X.-Y. Li, K. L. Tyler, J. M. Cullen, and H. W. Virgin. 1993. Lymphocytes protect against and are not required for reovirus induced myocarditis. J. Virol. 67:6119-6124.
43. Sosnovtsev, S. V., G. Belliot, K. O. Chang, V. G. Prikhodko, L. B. Thackray, C. E. Wobus, S. M. Karst, H. W. Virgin, and K. Y. Green. 2006. Cleavage map and proteolytic processing of the murine norovirus nonstructural polyprotein in infected cells. J. Virol. 80:7816-7831.
44. Souza, M., M. S. Azevedo, K. Jung, S. Cheetham, and L. J. Saif. 2008. Pathogenesis and immune responses in gnotobiotic calves after infection with human norovirus (HuNoV) genogroup II.4-HS66 strain. J. Virol. 82: 1777-1786.
45. Souza, M., S. M. Cheetham, M. S. Azevedo, V. Costantini, and L. J. Saif. 2007. Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain). J. Virol. 81:9183-9192.
46. Souza, M., V. Costantini, M. S. Azevedo, and L. J. Saif. 2007. A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII. 4 human norovirus in a gnotobiotic pig disease model. Vaccine 25:8448-8459.
47. Tacket, C. O., M. B. Sztein, G. A. Losonsky, S. S. Wasserman, and M. K. Estes. 2003. Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin. Immunol. 108:241-247.
48. Thackray, L. B., C. E. Wobus, K. A. Chachu, B. Liu, E. R. Alegre, K. S. Henderson, S. T. Kelley, and H. W. Virgin. 2007. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J. Virol. 81:10460-10473.
49. Tompkins, D. S., M. J. Hudson, H. R. Smith, R. P. Eglin, J. G. Wheeler, M. M. Brett, R. J. Owen, J. S. Brazier, P. Cumberland, V. King, and P. E. Cook. 1999. A study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun. Dis. Public Health 2:108-113.
50. Tyler, K. L., M. A. Mann, B. N. Fields, and H. W. Virgin. 1993. Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis. J. Virol. 67:3446-3453.
51. Tyler, K. L., H. W. Virgin, R. Bassel Duby, and B. N. Fields. 1989. Antibody inhibits defined stages in the pathogenesis of reovirus serotype 3 infection of the central nervous system. J. Exp. Med. 170:887-900.
52. Virgin, H. W., R. Bassel-Duby, B. N. Fields, and K. L. Tyler. 1988. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J. Virol. 62:4594-4604.
53. Ward, J. M., C. E. Wobus, L. B. Thackray, C. R. Erexson, L. J. Faucette, G. Belliot, E. L. Barron, S. V. Sosnovtsev, and K. Y. Green. 2006. Pathology of immunodeficient mice with naturally occurring murine norovirus infection. Toxicol. Pathol. 34:708-715.
54. Ward, V. K., C. J. McCormick, I. N. Clarke, O. Salim, C. E. Wobus, L. B. Thackray, H. W. Virgin, and P. R. Lambden. 2007. Recovery of infectious murine norovirus using pol II-driven expression of full-length cDNA. Proc. Natl. Acad. Sci. USA 104:11050-11055.
55. Westerman, L. E., H. M. McClure, B. Jiang, J. W. Almond, and R. I. Glass. 2005. Serum IgG mediates mucosal immunity against rotavirus infection. Proc. Natl. Acad. Sci. USA 102:7268-7273.
56. Wheeler, J. G., D. Sethi, J. M. Cowden, P. G. Wall, L. C. Rodrigues, D. S. Tompkins, M. J. Hudson, and P. J. Roderick. 1999. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. BMJ 318:1046-1050.
57. Wobus, C. E., S. M. Karst, L. B. Thackray, K. O. Chang, S. V. Sosnovtsev, G. Belliot, A. Krug, J. M. Mackenzie, K. Y. Green, and H. W. Virgin. 2004. Replication of a Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLOS Biol. 2:e432.
58. Wobus, C. E., L. B. Thackray, and H. W. Virgin. 2006. Murine norovirus: a model system to study norovirus biology and pathogenesis. J. Virol. 80:5104-5112.
59. Wyatt, R. G., R. Dolin, N. R. Blacklow, H. L. DuPont, R. F. Buscho, T. S. Thornhill, A. Z. Kapikian, and R. M. Chanock. 1974. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J. Infect. Dis. 129:709-714.
60. Youngman, K. R., M. A. Franco, N. A. Kuklin, L. S. Rott, E. C. Butcher, and H. B. Greenberg. 2002. Correlation of tissue distribution, developmental phenotype, and intestinal homing receptor expression of antigen-specific B cells during the murine anti-rotavirus immune response. J. Immunol. 168: 2173-2181.